US Patent 9315451 Tetracycline compounds
Patent 9315451 was granted and assigned to Tetraphase Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+327 characters)
Article
Patent abstract
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Chi-Li Chen0
Cuixiang Sun0
Louis Plamondon0
Magnus Rönn0
Minsheng He0
Roger B. Clark0
Xiao-Yi Xiao0
Yonghong Deng0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09315451 Tetracycline compounds US Patent 9315451 Tetracycline compounds
Infobox
Patent Number
093154510
Patent Number
93154510
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
093154510
Date of Patent
April 19, 2016
0Patent Application Number
133192980
Date Filed
May 7, 2010
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09315451 Tetracycline compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09315451
Date of patent
April 19, 2016
Patent application number
13319298
Date Filed
May 7, 2010
Patent primary examiner
Find more entities like US Patent 9315451 Tetracycline compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.